Akanda (STU:Y232) ROCE %: -5,270.82% (As of Dec. 2025)


STU:Y232 Akanda Corp STU:Y232
21 GF Score
Price €68.55
! 9 Warning Signs
View Full Analysis

What is Akanda ROCE %?

Akanda STU:Y232 21 ROCE % is -5,270.82% as of Dec. 2025. GuruFocus rates STU:Y232 with a GF Score™ of 21/100. The stock has 9 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Akanda's annualized ROCE % for the quarter that ended in Dec. 2025 was -5,270.82%.

Akanda  (STU:Y232) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Akanda ROCE % Related Terms

Akanda ROCE % Historical Data

* Premium members only.

The historical data trend for Akanda's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akanda ROCE % Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -406.34 -55.16 -24.61 -215.65 -1,943.69

Akanda Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -17.12 -272.31 -46.58 -68.67 -5,270.82
STU:Y232
21GF Score
Akanda Corp STU:Y232
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Akanda ROCE % Calculation

Akanda's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-39.661/( ( (7.558 - 3.474) + (5.291 - 5.294) )/ 2 )
=-39.661/( (4.084+-0.0029999999999992)/ 2 )
=-39.661/2.0405
=-1,943.69 %

Akanda's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-76.954/( ( (5.388 - 2.465) + (5.291 - 5.294) )/ 2 )
=-76.954/( ( 2.923 + -0.0029999999999992 )/ 2 )
=-76.954/1.46
=-5,270.82 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -5,270.82% mean?
Akanda (STU:Y232) has a ROCE % of -5,270.82% as of Dec. 2025.
Is Akanda's ROCE % too high?
Akanda's current ROCE % is -5,270.82%. Overall, Akanda has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Akanda's ROCE % compare to BFRI and BIOE?
Akanda's ROCE % of -5,270.82% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Akanda's current ROCE % is -5,270.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Akanda stock overvalued right now?
Akanda (STU:Y232) has a current ROCE % of -5,270.82%. The current ROCE % is -5,270.82%. Akanda's overall GF Score™ is 21/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Akanda (STU:Y232), the current ROCE % is -5,270.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Akanda Business Description

Other Exchanges AKAN:USAY232:Germany
Address c/o Gowling WLG (Canada) LLP, 100 King Street W, Suite 1600, Toronto, ON, CAN, M5X 1G5
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.
21GF Score

Get the complete analysis for STU:Y232

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.55
Price